- JP-listed companies
- Ina Research Inc.
- Income statement
Ina Research Inc. (E20922) Income statement
Market cap
P/E ratio
Inari Research provides contract testing services to help pharmaceutical companies evaluate drug safety and effectiveness using GLP-compliant laboratory facilities.
| 2010/03 | 2011/03 | 2012/03 | 2013/03 | 2014/03 | 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | |
| Revenue | 3,751 | 3,937 | 2,861 | 2,891 | 2,778 | 2,995 | 2,117 | 2,296 | 2,426 | 2,585 | 2,862 | 2,929 | 3,205 |
| Cost of revenue | - | - | - | 2,270 | 2,142 | 2,383 | 1,754 | 1,713 | 1,715 | - | - | - | - |
| Gross profit | - | - | - | 618 | 620 | 596 | 339 | 581 | 710 | 662 | 784 | 908 | 1,043 |
| Gross margin (%) | - | - | - | ||||||||||
| Operating expenses | - | - | - | 574 | 543 | 537 | 550 | 523 | 509 | 568 | 722 | 703 | 691 |
| Operating income | - | - | - | 44 | 77 | 60 | -210 | 58 | 202 | 93 | 62 | 205 | 352 |
| Income before tax | 187 | 94 | -61 | 27 | 148 | 32 | -227 | 31 | 166 | 61 | 30 | 177 | 340 |
| Provision for income taxes | - | - | - | 14 | 43 | 23 | 62 | 7 | 24 | 4 | 3 | -47 | 5 |
| Net income | 101 | 47 | -317 | 11 | 105 | 9 | -1,326 | 18 | 145 | 57 | 37 | 233 | 335 |
| Earnings per share | 3,366.83 | 1,576.73 | -105.83 | 3.76 | 34.96 | 2.88 | -442.27 | 6.13 | 48.32 | 18.9 | 12.2 | 77.61 | 111.65 |
| Diluted EPS | 3,354.29 | - | - | - | - | - | - | - | - | - | - | - | - |